Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 86 Records) |
| Query Trace: Disease and FGFR1[original query] |
|---|
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
| Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy. Urology 2021 6 157 93-101. Tully Karl H, Jütte Hendrik, Wirtz Ralph M, Jarczyk Jonas, Santiago-Walker Ademi, Zengerling Friedemann, Breyer Johannes, Sikic Danijel, Kriegmair Maximilian C, von Hardenberg Jost, Wullich Bernd, Taubert Helge, Weyerer Veronika, Stoehr Robert, Bolenz Christian, Burger Maximilian, Porubsky Stefan, Hartmann Arndt, Roghmann Florian, Erben Philipp, Eckstein Mark |
| Prognostic Genetic Biomarkers Based on Oncogenic Signaling Pathways for Outcome Prediction in Patients with Oral Cavity Squamous Cell Carcinoma. Cancers 2021 May 13 (11): . Fan Wen-Lang, Yang Lan-Yan, Hsieh Jason Chia-Hsun, Lin Tsung-Chieh, Lu Mei-Yeh Jade, Liao Chun- |
| rs9459874 and rs1012656 in CCR6/FGFR1OP confer susceptibility to primary biliary cholangitis. Journal of autoimmunity 2021 Dec 126 102775. Hitomi Yuki, Aiba Yoshihiro, Ueno Kazuko, Nishida Nao, Kawai Yosuke, Kawashima Minae, Yasunami Michio, Gervais Olivier, Ito Masahiro, Cordell Heather J, Mells George F, Nagasaki Masao, Tokunaga Katsushi, Tsuiji Makoto, Nakamura Mino |
| Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program. Translational oncology 2021 11 15 (1): 101266. Cassier Philippe A, Peyramaure Clémentine, Attignon Valery, Eberst Lauriane, Pacaud Camille, Boyault Sandrine, Desseigne Françoise, Sarabi Mathieu, Guibert Pierre, Rochefort Pauline, Marques Nathalie, Rivoire Michel, Dupré Aurélien, Peyrat Patrice, Terret Catherine, Ray-Coquard Isabelle, Coutzac Clélia, Pérol David, Blay Jean-Yves, Trédan Olivier, de la Fouchardière Christel |
GWAS meta-analysis followed by Mendelian randomization revealed potential control mechanisms for circulating ?-Klotho levels.
Human molecular genetics 2021 9 31 (5): 792-802. Gergei Ingrid, Zheng Jie, Andlauer Till F M, Brandenburg Vincent, Mirza-Schreiber Nazanin, Müller-Myhsok Bertram, Krämer Bernhard K, Richard Daniel, Falk Louise, Movérare-Skrtic Sofia, Ohlsson Claes, Davey Smith George, März Winfried, Voelkl Jakob, Tobias Jonathan |
| Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. British journal of cancer 2022 Sep . Fernandez-Garcia Daniel, Nteliopoulos Georgios, Hastings Robert K, Rushton Amelia, Page Karen, Allsopp Rebecca C, Ambasager Bana, Gleason Kelly, Guttery David S, Ali Simak, Charles Coombes R, Shaw Jacqueline |
| Correlation Analysis of Genotypes and Phenotypes in Chinese Male Pediatric Patients With Congenital Hypogonadotropic Hypogonadism. Frontiers in endocrinology 2022 13 846801. Wang Yi, Qin Miao, Fan Lijun, Gong Chunx |
| Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience. JCO precision oncology 2022 6 6 e2100289. Gerratana Lorenzo, Movarek Michael, Wehbe Firas, Katam Neelima, Mahalingam Devalingam, Donahue Jeannine, Shah Ami, Chae Young K, Mulcahy Mary, Tsarwhas Dean, Villaflor Victoria, Kalyan Aparna, Hussein Maha, Patel Jyoti, Chandra Sunandana, Platanias Leonidas C, Gradishar William, Cristofanilli Massimo, Behdad Am |
| Detection of brain somatic variation in epilepsy-associated developmental lesions. Epilepsia 2022 Jun . Bedrosian Tracy A, Miller Katherine E, Grischow Olivia E, Schieffer Kathleen M, LaHaye Stephanie, Yoon Hyojung, Miller Anthony R, Navarro Jason, Westfall Jesse, Leraas Kristen, Choi Samantha, Williamson Rachel, Fitch James, Kelly Benjamin J, White Peter, Lee Kristy, McGrath Sean, Cottrell Catherine E, Magrini Vincent, Leonard Jeffrey, Pindrik Jonathan, Shaikhouni Ammar, Boué Daniel R, Thomas Diana L, Pierson Christopher R, Wilson Richard K, Ostendorf Adam P, Mardis Elaine R, Koboldt Daniel |
| Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA. OncoTargets and therapy 2022 5 15 571-584. Li Jie, Chen Siwen, Xue Hui, Wang Haoyi, Huang Tianwei, Xie Hongya, He Jiang, Ke Cai, Yu Zhaonan, Ni B |
| Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients. Journal of translational medicine 2022 05 20 (1): 211. Liao Hao, Zhang Jiayang, Zheng Tiantian, Liu Xiaoran, Zhong Jianxin, Shao Bin, Dong Xiaoxi, Wang Xiaohong, Du Pan, King Bonnie L, Jia Shidong, Yu Jianjun, Li Huipi |
| Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (11): 2270-2277. Lassman Andrew B, Sepúlveda-Sánchez Juan Manuel, Cloughesy Timothy F, Gil-Gil Miguel J, Puduvalli Vinay K, Raizer Jeffrey J, De Vos Filip Y F, Wen Patrick Y, Butowski Nicholas A, Clement Paul M J, Groves Morris D, Belda-Iniesta Cristóbal, Giglio Pierre, Soifer Harris S, Rowsey Steven, Xu Cindy, Avogadri Francesca, Wei Ge, Moran Susan, Roth Patri |
| Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 2 35 (8): 1066-1074. Stradella Agostina, Gargallo Pablo, Cejuela Mónica, Petit Anna, Bosch-Schips Jan, Carbonell Paula, Recalde Sabela, Vethencourt Andrea, Fernandez-Ortega Adela, Falo Catalina, Gil-Gil Miguel, Vázquez Silvia, Obadia Verónica, Villanueva-Vázquez Rafael, Soler-Monsó Teresa, Calabria Inés, Pernas Son |
| Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort. Leukemia 2023 7 . Georgia Metzgeroth, Laurenz Steiner, Nicole Naumann, Johannes Lübke, Sebastian Kreil, Alice Fabarius, Claudia Haferlach, Torsten Haferlach, Wolf-Karsten Hofmann, Nicholas C P Cross, Juliana Schwaab, Andreas Reit |
| Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan. Breast cancer (Tokyo, Japan) 2023 12 . Bo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Han-Fang Cheng, Chun-Yu Liu, Ta-Chung Chao, Jiun-I Lai, Ling-Ming Tseng, Chi-Cheng Hua |
| Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
| How human genetic context can inform pathogenicity classification: FGFR1 variation in idiopathic hypogonadotropic hypogonadism. Human genetics 2023 10 . Wanxue Xu, Lacey Plummer, Stephanie B Seminara, Ravikumar Balasubramanian, Margaret F Lippinco |
| The ctDNA-based postoperative molecular residual disease status in different subtypes of early-stage breast cancer. Gland surgery 2023 1 11 (12): 1924-1935. Yang Yang, Zhang Jie, Li Jiao-Yang, Xu Lu, Wang Si-Ning, Zhang Jun-Qi, Xun Zhou, Xia Yu, Cao Jian-Bo, Liu Yang, Shi Li-Yan, Li Wei, Shi Yong-Lei, He Yuan-Ge, Gu De-Jian, Yu Zheng-Yuan, Chen Kai, Lan Ji |
| Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Annals of diagnostic pathology 2023 1 63 152082. Demleitner Madeleine, Erlenbach-Wünsch Katharina, Coras Roland, Erber Ramona, Polifka Iris, Eyüpo?lu Ilker, Fuchs Florian, Hartmann Arndt, Agaimy Abb |
| A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer. Journal of thoracic disease 2024 7 16 (6): 3782-3793. Christine Auberle, Feng Gao, Mark Sloan, Daniel Morgensztern, Linda Winkler, Jeffrey P Ward, Siddhartha Devarakonda, Timothy P Rearden, Ramaswamy Govindan, Saiama N Waq |
| Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer. Cancer medicine 2024 6 13 (12): e7384. Shang-Hung Chen, Ka-Po Tse, Yen-Jung Lu, Shu-Jen Chen, Yu-Feng Tian, Kien Thiam Tan, Chien-Feng |
| Somatic KMT2D loss-of-function mutations in lung squamous cell carcinoma: a single-center cohort study. Journal of thoracic disease 2024 6 16 (5): 3338-3349. Zekui Fang, Xiping Wu, Li Xiao, Chunli Wang, Yanyan Zhao, Qingchao Zhang, Paola Anna Jablonska, Alonso La Rosa, Wolfram C M Dempke, Muhammad Furqan, Huizhen F |
| Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification. Frontiers of medicine 2024 5 . Rui Fu, Yuanyuan Xiong, Miao Cai, Fang Li, Rongrong Chen, Yilong Wu, Wenzhao Zho |
| Clinicogenomic characterization of inflammatory breast cancer. bioRxiv : the preprint server for biology 2024 5 . Nolan Priedigkeit, Beth Harrison, Robert Shue, Melissa Hughes, Yvonne Li, Gregory J Kirkner, Liam F Spurr, Marie Claire Remolano, Sarah Strauss, Janet Files, Anne-Marie Feeney, Libby Grant, Ayesha Mohammed-Abreu, Ana Garrido-Castro, Romualdo Barroso Sousa, Brittany Bychkovsky, Faina Nakhlis, Jennifer R Bellon, Tari A King, Eric P Winer, Neal Lindeman, Bruce E Johnson, Lynette Sholl, Deborah Dillon, Beth Overmoyer, Sara M Tolaney, Andrew Cherniack, Nancy U Lin, Filipa Lyn |
| Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases. British journal of cancer 2024 5 . Thomas Aparicio, Julie Henriques, Magali Svrcek, Aziz Zaanan, Sylvain Manfredi, Andrea Casadei-Gardini, David Tougeron, Jean-Marc Gornet, Marine Jary, Eric Terrebonne, Guillaume Piessen, Pauline Afchain, Cédric Lecaille, Marc Pocard, Thierry Lecomte, Margherita Rimini, Frédéric Di Fiore, Valérie Le Brun Ly, Stefano Cascinu, Dewi Vernerey, Pierre Laurent Pu |
| Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1. JCO precision oncology 2024 4 8 e2300406. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Ajjai S Alva, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
| Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2. JCO precision oncology 2024 4 8 e2300407. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
| FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma. Contemporary oncology (Poznan, Poland) 2024 1 27 (3): 211-216. Julia Pikul, Anna Rzepakowska, Marcin Machnicki, Tomasz Stok?o |
| Association of genetically proxied cancer-targeted drugs with cardiovascular diseases through Mendelian randomization analysis. Journal of translational medicine 2025 1 23 (1): 14. Chuchun Fang, Xuewei Liu, Chen Yu, Songlin Li, Xueying Liu, Shifeng Qiu, Hongbin Liang, Caiwen Ou, Jiancheng X |
- Page last reviewed:Feb 1, 2024
- Content source: